WuXi XDC’s Development Platforms Deliver Consistent & Scalable Conjugation Processes
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
Scientific Posters
Throughout all stages of your product development, WuXi XDC utilizes industry proven platforms to ensure cost-effective and robust execution of your project needs while also driving innovation to provide greater efficiency, lower the cost of goods and deliver safer, more efficacious, and higher quality bioconjugates. The following scientific posters, presented at various industry trade events and conferences, provide a snapshot of our various technology platforms and services to help you better reach your discovery, development, and clinical or commercial manufacturing goals.
-
-
Application of Flow Chemistry Process in Linker-Payload Synthesis -
WuXiDAR4: A simple but powerful approach to produce homogeneous ADC products -
An Integrated Approach to Accelerate the ADC Discovery, with Novel DAR Control and Developability Assessment Toolbox -
High-Throughput Conjugation Platform Used for Screening ADCs -
A Novel Conjugation Technology for Native Antibodies that Generates ADCs with a Narrowly Distributed DAR
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?